Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease

被引：0
作者：
Pratishtha Chatterjee
Henrik Zetterberg
Kathryn Goozee
Chai K. Lim
Kelly R. Jacobs
Nicholas J. Ashton
Abdul Hye
Steve Pedrini
Hamid R. Sohrabi
Tejal Shah
Prita R. Asih
Preeti Dave
Kaikai Shen
Kevin Taddei
David B. Lovejoy
Gilles J. Guillemin
Kaj Blennow
Ralph N. Martins
机构：
[1] Macquarie University,Department of Biomedical Sciences
[2] Edith Cowan University,School of Medical Health and Sciences
[3] University of Gothenburg,Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology
[4] Sahlgrenska University Hospital,Clinical Neurochemistry Laboratory
[5] UCL Institute of Neurology,Department of Neurodegenerative Disease
[6] Queen Square,Clinical Research Department
[7] UK Dementia Research Institute at UCL,School of Psychiatry and Clinical Neurosciences
[8] KaRa Institute of Neurological Disease,Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute
[9] Sydney,NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia
[10] Anglicare,Wallenberg Centre for Molecular and Translational Medicine
[11] Sydney,School of Medical and Health Sciences
[12] University of Western Australia,undefined
[13] King’s College London,undefined
[14] South London and Maudsley NHS Foundation,undefined
[15] University of Gothenburg,undefined
[16] Australian Alzheimer’s Research Foundation,undefined
[17] Australian eHealth Research Centre,undefined
[18] CSIRO,undefined
[19] The Cooperative Research Centre for Mental Health,undefined
[20] Edith Cowan University,undefined
[21] Ralph & Patricia Sarich Neuroscience Research Institute,undefined
来源：
Journal of Neuroinflammation | / 16卷
关键词：
Blood markers; Neuroinflammation; Neurodegeneration; Alzheimer’s disease; Neurofilament light chain; Amyloid-beta; Kynurenine pathway; Brain amyloid-beta; Blood amyloid-beta;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Stabilization of a Membrane-Associated Amyloid-β Oligomer for Its Validation in Alzheimer's Disease
    Serra-Batiste, Montserrat
    Tolchard, James
    Giusti, Fabrice
    Zoonens, Manuela
    Carulla, Natalia
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2018, 5
  • [22] Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease
    Aschenbrenner, Andrew J.
    Gordon, Brian A.
    Fagan, Anne M.
    Schindler, Suzanne E.
    Balota, David A.
    Morris, John C.
    Hassenstab, Jason J.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 74 (04) : 1119 - 1129
  • [23] Plasma Neurofilament Light Chain Levels Are Associated With Cortical Hypometabolism in Alzheimer Disease Signature Regions
    Mayeli, Mahsa
    Mirshahvalad, Seyed Mohammad
    Aghamollaii, Vajiheh
    Tafakhori, Abbas
    Abdolalizadeh, Amirhussein
    Rahmani, Farzaneh
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2019, 78 (08) : 709 - 716
  • [24] The Kynurenine Pathway, Aryl Hydrocarbon Receptor, and Alzheimer's Disease
    Malagon, Enoc Mariano Cortes
    Ornelas, Adolfo Lopez
    Gomez, Irlanda Olvera
    Delgado, Jose Bonilla
    BRAIN SCIENCES, 2024, 14 (09)
  • [25] Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants
    Chatterjee, Pratishtha
    Goozee, Kathryn
    Sohrabi, Hamid R.
    Shen, Kaikai
    Shah, Tejal
    Asih, Prita R.
    Dave, Preeti
    ManYan, Candice
    Taddei, Kevin
    Chung, Roger
    Zetterberg, Henrik
    Blennow, Kaj
    Martins, Ralph N.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 63 (02) : 479 - 487
  • [26] Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
    de Wolfa, Frank
    Ghanbaria, Mohsen
    Lichera, Silvan
    McRae-McKeea, Kevin
    Grasa, Luuk
    Weverlinga, Gerrit Jan
    Wermelinga, Paulien
    Sedaghata, Sanaz
    Ikrama, M. Kamran
    Wazirya, Reem
    Koudstaala, Wouter
    Klapa, Jaco
    Kostensea, Stefan
    Hofmana, Albert
    Andersona, Roy
    Goudsmita, Jaap
    Ikrama, M. Arfan
    BRAIN, 2020, 143 : 1220 - 1232
  • [27] Amyloid-β: A double agent in Alzheimer's disease?
    Yu, Hao
    Wu, Jie
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [28] Amyloid-β-directed immunotherapy for Alzheimer's disease
    Lannfelt, L.
    Relkin, N. R.
    Siemers, E. R.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (03) : 284 - 295
  • [29] Citrullination of Amyloid-β Peptides in Alzheimer's Disease
    Mukherjee, Soumya
    Perez, Keyla A.
    Dubois, Celine
    Nisbet, Rebecca M.
    Li, Qiao-Xin
    Varghese, Shiji
    Jin, Liang
    Birchall, Ian
    Streltsov, Victor A.
    Vella, Laura J.
    McLean, Catriona
    Barham, Kevin J.
    Roberts, Blaine R.
    Masters, Colin L.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (19): : 3719 - 3732
  • [30] Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
    Chatterjee, Pratishtha
    Pedrini, Steve
    Ashton, Nicholas J.
    Tegg, Michelle
    Goozee, Kathryn
    Singh, Abhay K.
    Karikari, Thomas K.
    Simren, Joel
    Vanmechelen, Eugeen
    Armstrong, Nicola J.
    Hone, Eugene
    Asih, Prita R.
    Taddei, Kevin
    Dore, Vincent
    Villemagne, Victor L.
    Sohrabi, Hamid R.
    Zetterberg, Henrik
    Masters, Colin L.
    Blennow, Kaj
    Martins, Ralph N.
    ALZHEIMERS & DEMENTIA, 2022, 18 (06) : 1141 - 1154
12345